Today's Morning Movers and Top Ratings: MRNA, GME, MRK, CCL and More

$Deutsche Bank(DB.US)$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.

$Merck & Co(MRK.US)$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.

$Trump Media & Technology(DJT.US)$ stock jumped 14%, following gains after its Nasdaq debut.

$Robinhood(HOOD.US)$ stock climbed 6%, after launching a new credit card for personal finance market expansion.

$ShockWave Medical(SWAV.US)$ stock rose 1.6%, continuing gains on reports of potential acquisition by Johnson & Johnson.

$Novocure(NVCR.US)$ stock soared 35% after its cancer therapy succeeded in a late-stage trial.

$Moderna(MRNA.US)$ stock rose 4.3% following a funding agreement for mRNA flu vaccine development.

$Carnival(CCL.US)$ 's shares increased 2% in anticipation of its Q1 earnings report, with expectations of a 17 cent loss per share and $5.33 billion in revenue. Despite a 130% surge in 2023 amid the industry's Covid recovery, the stock has fallen 8% this year, underperforming compared to its peers.

$GameStop(GME.US)$ shares nosedived over 17% following a significant drop in fourth-quarter revenue year-over-year. The company also announced cost-cutting workforce reductions during the quarter.